Emyria (ASX:EMD) share price up 131% this month. Here's why

The Emyria Ltd (ASX: EMD) share price has been one of the best performers over the month, rising an astonishing 131%. We take a closer look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Emyria Ltd (ASX: EMD) share price has been one of the best performers over the month. The share price has risen an astonishing 131%. Today alone, shares in the healthcare technology and services company are up 13% to 27 cents at the time of writing.

During the late afternoon trade, the company's shares were being picked up for 26.5 cents. This reflects an all-time high for the Emyria share price.

We take a closer look into what's moving its shares over the past few weeks.

What's the go with Emyria?

At the start of February, shares in the healthcare technology and services company were swapping hands for as little as 11 cents. However, a raft of positive announcements led investors to revaluate the company's prospect, sending the Emyria share price higher.

The first release was related to the company winning a digital health grant from the Western Australian government early this month. For this project, Emyria took the leadership role. This aimed to help boost the state's digital health infrastructure and capacity in dealing with major health concerns.

Following the digital health grant, the company announced last week that it added a second Melbourne clinic to its portfolio. The expanded presence comes after Emyria revealed that it has achieved record patient appointments in January 2021. In total, the company now has six locations across Australia gathering clinical data to improve the platform for patient care.

Quick take on Emyria

Emyria, formerly known as Emerald Clinics, operates a network of specialist medical clinics and purpose-built, remote patient monitoring technologies.

The company captures real-world clinical data. This is used to provide consultation letters, containing information on prescription, recommended dosage, and duration of cannabinoid-based medicines.

Emyria share price performance

As noted, the Emyria share price began the month at 11 cents but has surged following positive investor sentiment. The company's shares hit an all-time high today of 26.5 cents and could go higher based on its market capitalisation.

Emyria's current value stands at around $57 million according to its current share price. This represents an opportunity for explosive growth should the company continue to impress investors with its progress.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A Chinese investor sits in front of his laptop looking pensive and concerned about pandemic lockdowns which may impact ASX 200 iron ore share prices
Share Market News

Why are Liontown shares pushing higher today and should you invest?

Let's see what the lithium miner has announced this morning.

Read more »

Three rockets heading to space
Share Gainers

Guess which ASX All Ords mining stock is rocketing 36% on big news

Investors are piling into the ASX All Ords miner today. But why?

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Initiation: Bell Potter just put a buy rating on this ASX 200 blue chip share

This blue chip has received a buy recommendation from the top broker.

Read more »

Miner and company person analysing results of a mining company.
Share Market News

Liontown Resources defers Ford repayments and amends lithium delivery deals

Liontown Resources defers Ford repayments and gains new sales flexibility under amended lithium offtake and debt deals.

Read more »

A man in a suit face palms at the downturn happening with shares today.
Mergers & Acquisitions

Guess which ASX 200 stock is crashing 13% on big news

This stock is being sold off on Thursday. But why?

Read more »

People sitting in rows in a meeting with one person holding their hand up as if to ask a question.
Broker Notes

Macquarie names 3 ASX All Ords stocks to deliver the most negative earnings surprises during AGM season

Macquarie expects these three stocks to disappoint during their AGMs.

Read more »

Retired couple hugging and laughing.
Broker Notes

Why Macquarie expects this $2.5 billon ASX healthcare share to rocket 36%

Macquarie forecasts strong outperformance for this ASX healthcare share.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Share Market News

5 things to watch on the ASX 200 on Thursday

A better session is expected for Aussie investors today after a sold night in the US.

Read more »